Objectives We have confirmed the diagnostic value of protein induced by vitamin K absence
or antagonist-II (PIVKA-II) in a French cohort of patients with hepatocellular carcinoma …

Objective: As a marker for Hepatocellular Carcinoma (HCC), Protein Induced by Vitamin K
Absence II (PIVKA-II) seems to be superior to alpha fetoprotein (AFP). To better characterize …

OBJECTIVE: Hepatocellular carcinoma (HCC) is a primary liver tumor derived from
metabolic or viral chronic hepatitis, with few treatment options in advanced cases. New …

Simple Summary The use of tumor biomarkers, although debated, for the surveillance of
patients at risk of HCC, is common practice in many clinical centers. Here, we investigated …

Protein induced by Vitamin K absence or antagonists-II (PIVKA-II) is a diagnostic marker of
hepatocellular carcinoma (HCC). We aimed to investigate the predictive role of PIVKA-II and …

Protein induced by vitamin K absence or antagonist II (PIVKA-II) is a promising serum
marker for hepatocellular carcinoma (HCC). There are limited data on its cutoff value in HCC …

Background and Objectives: We aim to compare the diagnostic performance of Protein
induced by vitamin K absence-II (PIVKA-II), a biomarker for hepatocellular carcinoma (HCC) …

Protein induced by vitamin K absence or antagonist II (PIVKA-II) plays a critical role in the
diagnosis of hepatocellular carcinoma (HCC), however, studies on its efficacy in diagnosing …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading
cause of cancer-related death worldwide. Due to the lack of efficient tools for early detection …

The high morbidity and mortality of hepatocellular carcinoma (HCC) has encouraged the
search for new biomarkers to be used alongside alpha-foetoprotein (AFP) and imaging tests …